The groundbreaking FIREFLY-1 trial tested the efficacy of oral drug, tovorafenib, in brain tumour patients with results showing a 50 per cent tumour shrinkage in two thirds of patients.
OCD BOUNCE, an Australian-first paediatric public health service, is helping to bridge the gap and advance treatment for young people living with obsessive-compulsive disorder.
The two-day event hosted discussions by leading experts of not only the latest scientific developments in paediatric advanced therapeutics, but also their clinical counterparts.
The Biospecimen Research Services at The Childrens Hospital at Westmead is celebrating its 25th anniversary.
Hospital Scientist Dr Benjamin Nash has been awarded an AGRF grant to support his research journey, enabling his team access to long read sequencing technology.
Over $2 million in funding has been awarded by Luminesce Alliance to support the Providing Enhanced Access to Child Health Services Evaluation (PEACH-E) project.
More than $18.7 million in funding has been allocated to researchers across SCHN through the latest MRFF grant.
Dr Bhavna Padhye and Dr Rebecca Poulos have been awarded a joint fellowship to support a translational project for paediatric cancer.
New research has shown newborn bloodspot screening is more effective than conventional clinical diagnosis pathways for improving health outcomes in infants with SMA.
World-leading gene therapy experts at Sydney Children’s Hospitals Network have shared their knowledge and experience at the BIO International Convention in San Diego.